The Effect of Methyl-Derivatives of Flavanone on MCP-1, MIP-1β, RANTES, and Eotaxin Release by Activated RAW264.7 Macrophages.
Małgorzata KłósekAnna Kurek-GóreckaRadosław BalwierzAgnieszka Krawczyk-ŁebekEdyta Kostrzewa-SusłowJoanna BronikowskaDagmara JaworskaZenon Paweł CzubaPublished in: Molecules (Basel, Switzerland) (2024)
Chemokines, also known as chemotactic cytokines, stimulate the migration of immune cells. These molecules play a key role in the pathogenesis of inflammation leading to atherosclerosis, neurodegenerative disorders, rheumatoid arthritis, insulin-resistant diabetes, and cancer. Moreover, they take part in inflammatory bowel disease (IBD). The main objective of our research was to determine the activity of methyl-derivatives of flavanone, namely, 2'-methylflavanone ( 5B ), 3'-methylflavanone ( 6B ), 4'-methylflavanone ( 7B ), and 6-methylflavanone ( 8B ), on the releasing of selected cytokines by RAW264.7 macrophages activated by LPS. We determined the concentration of chemokines belonging to the CC chemokine family, namely, MCP-1, MIP-1β, RANTES, and eotaxin, using the Bio-Plex Magnetic Luminex Assay and the Bio-PlexTM 200 System. Among the tested compounds, only 5B and 6B had the strongest effect on inhibiting the examined chemokines' release by macrophages. Therefore, 5B and 6B appear to be potentially useful in the prevention of diseases associated with the inflammatory process.
Keyphrases
- type diabetes
- rheumatoid arthritis
- oxidative stress
- cardiovascular disease
- glycemic control
- signaling pathway
- disease activity
- squamous cell carcinoma
- structure activity relationship
- adipose tissue
- ankylosing spondylitis
- molecularly imprinted
- mass spectrometry
- ulcerative colitis
- insulin resistance
- systemic sclerosis